Pharma Mar Dividends and Buybacks
Dividend criteria checks 0/6
Pharma Mar is a dividend paying company with a current yield of 0.87%.
Key information
0.9%
Dividend yield
1.0%
Buyback Yield
| Total Shareholder Yield | 1.9% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 12.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.650 |
| Payout ratio | 1,833% |
Recent dividend and buyback updates
Recent updates
Pharma Mar, S.A.'s (BME:PHM) Price Is Right But Growth Is Lacking After Shares Rocket 55%
Oct 16
Pharma Mar, S.A.'s (BME:PHM) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jul 28Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65
Jun 01Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry
May 28Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, PHM has been paying a dividend for less than 10 years.
Growing Dividend: PHM's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| Pharma Mar Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PHM) | 0.9% |
| Market Bottom 25% (ES) | 2.4% |
| Market Top 25% (ES) | 5.5% |
| Industry Average (Biotechs) | 1.6% |
| Analyst forecast (PHM) (up to 3 years) | 0.9% |
Notable Dividend: PHM's dividend (0.87%) isn’t notable compared to the bottom 25% of dividend payers in the Spanish market (2.44%).
High Dividend: PHM's dividend (0.87%) is low compared to the top 25% of dividend payers in the Spanish market (5.53%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (1832.8%), PHM's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: PHM is paying a dividend but the company has no free cash flows.